Scientists Discover Hidden Aging Process in Gut That Fuels Cancer Risk
Finn's Take· TL;DR- Scientists discovered ACCA drift, an aging process in gut stem cells that increases cancer risk through epigenetic changes following predictable patterns.
- Declining iron levels impair TET enzymes, causing harmful DNA methylations to accumulate and silence key genes, accelerating cellular aging.
- Researchers showed this aging process is reversible by reactivating TET enzymes, opening potential cancer prevention through iron metabolism or enzyme-targeting therapies.
The Hidden Molecular Clock
Deep within our intestines, a silent countdown is underway. The human gut replaces its cells faster than any other tissue in the body. Every few days, fresh cells are produced by specialized stem cells that keep the intestinal lining healthy. But as we age, something goes wrong with this remarkable renewal system.
Scientists have discovered a previously unknown aging program called ACCA (Aging- and Colon Cancer-Associated) drift, a gradual shift in epigenetic markers that becomes stronger as people age. A new study published in Nature Aging shows that these changes follow a clear pattern rather than appearing at random. This finding challenges our understanding of how cancer risk accumulates over time.
Over time, however, these stem cells begin to accumulate epigenetic changes. These are chemical tags attached to DNA that work like on and off switches, controlling which genes stay active and which are turned down. Unlike genetic mutations that alter DNA sequences, these epigenetic changes modify how genes function without changing the underlying genetic code.
The Iron Connection
The research team uncovered the surprising mechanism behind this drift. As intestinal cells age, they take in less iron while releasing more of it. This reduces the amount of iron (II) available in the cell nucleus. This seemingly minor change triggers a cascade of molecular events with profound consequences.
Iron (II) is essential for the proper function of TET (ten-eleven translocation) enzymes, which normally help remove excess DNA methylations. When iron levels drop, these enzymes no longer work efficiently. As a result, excess DNA methylations remain in place instead of being broken down.
"When there's not enough iron in the cells, faulty markings remain on the DNA. And the cells lose their ability to remove these markings," says Dr. Anna Krepelova. As TET activity declines, DNA methylations build up, key genes are switched off, and they "fall silent." This chain reaction further speeds up epigenetic drift.
Cancer Risk Implications
This explains why the intestines of older people contain a veritable patchwork of crypts that have remained young and others that have aged significantly, and why certain regions are particularly susceptible to producing more degenerated cells, which promotes cancer growth. The discovery helps explain why colorectal cancer risk increases dramatically with age.
Age-related inflammation in the gut makes the problem worse. This creates a perfect storm where declining iron metabolism, impaired DNA repair mechanisms, and chronic inflammation work together to create an environment where cancer can more easily take hold.
The research also revealed that this process affects different areas of the intestine unevenly, creating a mosaic of cellular ages within the same organ. Some regions maintain their youthful characteristics while others rapidly accumulate age-related changes, potentially explaining why certain areas become more prone to cancer development.
Hope for Intervention
Perhaps most , the researchers demonstrated that this aging process isn't inevitable. "Both approaches reactivated TET enzymes and allowed cells to start clearing excess DNA methylations again. This means that epigenetic aging does not have to be a fixed, final state," Dr. Anna Krepelova says.
"For the first time, we are seeing that it is possible to tweak the parameters of aging that lie deep within the molecular core of the cell." This breakthrough suggests that interventions targeting iron metabolism or TET enzyme activity could potentially slow or reverse this aging process.
The findings open new avenues for cancer prevention strategies. Rather than waiting for tumors to develop, future treatments might focus on maintaining the molecular machinery that keeps our cells young. Understanding how iron homeostasis affects cellular aging could lead to targeted therapies that preserve the gut's remarkable ability to renew itself throughout our lives.